Laser-Based Segment to Hold Larger Aesthetic Medical Devices Market Share During 2023-2031

According to our new research study on "Aesthetic Medical Devices Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis," the market value is projected to grow from US$ 19,209.76 million in 2023 to US$ 44,595.69 million by 2031. The Aesthetic Medical Devices Market is further anticipated to record a CAGR of 11.1% from 2022 to 2030. The aesthetic medical devices market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. Rise in medical tourism globally, increase in prevalence of skin disorders and consumer awareness about skincare treatments, surge in adoption of minimally invasive and noninvasive aesthetic procedures, rising spending on medical procedures in developing countries and new product launches & approvals, and technological advancements associated with medical aesthetic devices are impacting the market growth. The manufacturers are developing user-friendly devices to expand their customer base. Also, the manufacturers are partnering with beauty clinics to expand their presence in the market.

North America has dominated the aesthetic medical devices market. The US held the largest share in 2023 owing to the increased number of aesthetic procedures has over the last 10 years. Also, technological developments have increased the number of minimally invasive and noninvasive procedures. According to the American Society of Plastic Surgeons, in 2022, 26.2 million surgical and minimally invasive operations were carried out in the US. Additionally, as per ASAPS 2020, 15.6 million cosmetic procedures were recorded in 2020, which included ~2.3 million cosmetic surgical and 13.2 million cosmetic minimally invasive procedures. Intense pulsed light (IPL) treatment is among the top 5 cosmetic minimally invasive procedures, with over 827,000 IPL procedures performed in the country in 2020. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Based on technology, the aesthetic medical devices market is divided into segmented into laser-based, light-based, electromagnetic energy-based, ultrasound-based, cryolipolysis, suction-based, plasma energy-based, ems, and microwave. The laser-based segment held largest market share in 2023.

By application, the market is segmented into acne and acne scars, hair removal, facial skin resurfacing, photorejuvenation, skin tightening, feminine rejuvenation, fat reduction and body contouring, tattoos and pigmentation, vascular lesions, cellulite reduction, and others. The acne and acne scars segment held the largest share of the market in 2023.

In terms of end user, the market is categorized into dermatology and cosmetic clinics, hospitals and clinics, medical spas, and home use. The dermatology and cosmetic clinics segment dominated the market in 2023.

Alma Lasers, Merz Pharma GmbH & Co KGaA, Bausch Health Companies Inc, Lumenis Be Ltd, Venus Concept Inc., Cutera Inc, Fotona, InMode, Asclepion Laser Technologies GmbH, Cynosure LLC, and Sientra Inc. are a few key companies profiled in the aesthetic medical devices market report.

Companies operating in the aesthetic medical devices market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the aesthetic medical devices market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall aesthetic medical devices market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

- Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage FLX and the TR-4 Return Pad by China's National Medical Products Administration (NMPA). The TR-4 Return Pad is approved for use by the U.S. Food & Drug Administration (as part of the Thermage FLX device registration). (Source: Bausch Health Companies Inc, Press Release, 2024)

- CUTERA, INC., a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. (Source: Cutera Inc, Press Release, 2024)

- Venus Concept Inc., a global medical aesthetic technology leader, announced the commercial launch of its new multi-application platform Venus Versa Pro in the US. Venus Versa Pro supports 10 different applicators that can be used individually or in combination to target a wide range of aesthetic conditions, including skin texture, acne vulgaris, vascular and pigmented lesions, facial wrinkles and many more. (Source: Venus Concept Inc., Press Release, 2023)


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com